Menghis Bairu, MD

Chairman and CEO
Bairex Institute of Health Education and Research
v
Menghis Bairu is a physician, entrepreneur, coach, business executive, editor, author, and philanthropist. He has 30 years of international experience in biotechnology, pharmaceutical, drug delivery, global health, and non-profit arenas.

Dr. Bairu is co-founder and CEO of Bio Usawa Inc., a privately held company developing and manufacturing quality and affordable Monoclonal Antibodies for patients in Africa and beyond. In addition, he is founder, chairman, and CEO of Proxenia Venture Partners, which provides capital, management talent, and access to global networks of experts to companies in late preclinical and early-stage clinical development in biotechnology addressing global challenges and improving patient lives.

Previously, Dr. Bairu served as Executive Chairman of Treos Bio, a start-up company using computational biology to develop precision cancer immunotherapies tailored to patients’ genetics. In addition, he is founder and chairman Emeritus of Serenus Biotherapeutics, an emerging market-focused specialty biopharmaceutical company. In that role, he raised $43 million in series A funding.

Dr. Bairu concurrently served as EVP, CMO, Head of Global Development for Elan, and President/CEO of Speranza Therapeutics. As EVP and CMO, Dr. Bairu was a member of Elan’s Operating Committee. He successfully led corporate R&D due diligence processes, resulting in a transaction with J&J valued at approximately $1.5 billion and in 2013, the sale of Elan to Perrigo for $8.6 billion.
Before joining Elan, Dr. Bairu worked at Genentech for over six years in several managed care, medical, and commercial roles (Rituximab, Herceptin, TNK, tPA, Growth Hormone). He also served on the board of directors of various companies, including One World Health, a non-profit drug development company funded by the Bill and Melinda Gates Foundation.

Dr. Bairu currently serves as Adjunct Professor at the University of California, San Francisco School of Medicine, where he lectures on global clinical trials’ design, development, and conduct.
x
x
Pre-Readings
x
Get Access
x
x
Search
x
x